SCHEMBL6894820

SCHEMBL6894820

CC(O)C(N)C(NCc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C19 P33261 2/20 0.60
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPK1 P28482 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GABRB1 P18505 1/20 0.41
GABRB2 P47870 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895745 0.90 LMNA (0.47) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL3649450 0.88 TACR1 (0.46) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL6895808 0.87 SMN1; SMN2 (0.57) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL6890175 0.86 CYP1A2 (0.48) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL6890574 0.85 PLA2G1B (0.52) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL6892337 0.85 LMNA (0.52) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL6886251 0.84 TDP1 (0.52) MEN1KMT2AMAPK1NPSR1POLB
SCHEMBL6887798 0.83 GAA (0.45) CYP1A2CYP2D6CYP2C19MAPK1NPSR1
SCHEMBL6895924 0.83 ALDH1A1 (0.48) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL3641583 0.82 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed